KRAS and Pancreatic Cancer: Entering a New Era of Treatment

In this webinar, PanCAN Chief Scientific and Medical Officer Anna Berkenblit, MD, MMSc, hosts a panel discussion focused on KRAS and pancreatic cancer. Topics include: • What KRAS is and why it's critical for patients diagnosed with pancreatic cancer to know if their tumor has a KRAS mutation • The latest research related to KRAS and beyond, including clinical trials happening now that stand to change the treatment landscape • The important role patients play in advocating for biomarker testing, clinical trials and new treatment options for KRAS-driven cancers • How PanCAN Patient Services can help patients get biomarker testing to identify KRAS and other mutations as well as navigate treatment options, including clinical trials ################ Do you know someone diagnosed with pancreatic cancer? The expert Patient Services case managers at PanCAN partner with patients and families at every step, offering free, personalized information and resources. Call 877-2-PANCAN, email [email protected] or visit http://pcan.at/pty. Associates are available Monday – Friday, 7 a.m. – 5 p.m. PT. ################ CONNECT WITH US WEBSITE: http://pcan.at/PC FACEBOOK:   / pancan   TWITTER:   / pancan   INSTAGRAM:   / pancan   YOUTUBE:    / stoppancreaticcancer   ################ ABOUT PANCREATIC CANCER ACTION NETWORK The Pancreatic Cancer Action Network’s (PanCAN) vision is to create a world in which all patients with pancreatic cancer will thrive. Our mission is to take bold action to improve the lives of everyone impacted by pancreatic cancer by advancing scientific research, building community, sharing knowledge, and advocating for patients.